A tissue bank that failed to follow its own anti-infection rules may have shipped tainted human tissue to hospitals, according to a Food and Drug Administration report. The agency issued a seven-page warning letter to AlloSource, Centennial, Colo., in July for violating its own policies in handling cadaver skeletal and muscular tissue. The company ships to hospitals in Southern California, Colorado, Illinois, Missouri and Wyoming. "We appreciate the scrutiny they've given us, and we believe we're probably 45 to 60 days away from significantly being done with these issues," said AlloSource President and CEO Thomas Cycyota, adding that the company had spent $1 million on improvements. FDA inspectors said AlloSource sent out tissue from a cadaver that tested positive for the bacteria Clostridium perfringens. Cycyota said the company has been working with the recipients' surgeons and none has noticed any medical problems with their patients. Earlier this month, the FDA shut down part of CryoLife Corp., Kennesaw, Ga., saying 27 people developed serious infections after receiving tissue processed by the company. One of them had died, according to the FDA. -- by the Associated Press
Colo. firm may have shipped tainted tissue: FDA
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.